Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy.

Knudson KM, Hicks KC, Alter S, Schlom J, Gameiro SR

DOI: 10.1186/s40425-019-0551-y
Published: 2019 Mar 21
Container: Journal for immunotherapy of cancer
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s40425-019-0551-y,
  title = {Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy.},
  author = {Knudson KM and Hicks KC and Alter S and Schlom J and Gameiro SR},
  year = {2019},
  journal = {Journal for immunotherapy of cancer},
  doi = {10.1186/s40425-019-0551-y},
  url = {https://doi.org/10.1186/s40425-019-0551-y}
}

RIS

TY  - JOUR
TI  - Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy.
AU  - Knudson KM
AU  - Hicks KC
AU  - Alter S
AU  - Schlom J
AU  - Gameiro SR
PY  - 2019
JO  - Journal for immunotherapy of cancer
DO  - 10.1186/s40425-019-0551-y
UR  - https://doi.org/10.1186/s40425-019-0551-y
ER  -

APA

KM, K., KC, H., S, A., J, S., & SR, G. (2019). Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy.. Journal for immunotherapy of cancer. https://doi.org/10.1186/s40425-019-0551-y

Source records

pubmed · retrieved 2026-09-26T00:16:34.189Z